Amiodarone as an anti-arrhythmia agent
Giec, L.
Kardiologia Polska 28(1): 1-9
1985
ISSN/ISBN: 0022-9032 PMID: 4010140 Document Number: 243441
Document emailed within 1 workday
Related Documents
Kobayashi, K.; Itoh, S.; Fukuzaki, H. 1985: Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone Nihon Rinsho. Japanese Journal of Clinical Medicine 43(11): 2428-2434Fossati, C. 1985: Collateral effects of an anti-arrhythmic agent: amiodarone La Clinica Terapeutica 114(6): 509-514
Heinrich, K. 1980: Mexitil, a new anti-arrhythmia agent Medizinische Klinik 75(6): 235-237
Steinbeck, G. 1991: Which anti-arrhythmia agent in continuous ventricular tachycardia? Medizinische Klinik 86(12): 659-660
Husson, J. 1975: Amiodarone, an anti-arrhythmic agent (apropos of a case of ventricular recurrent tachycardia in a coronary patient) Lille Medical: Journal de la Faculte de Medecine et de Pharmacie de l'Universite de Lille 20(2): 109-112
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386
Zil'berter, I.I.; Khodorov, B.I.; Shubert, B. 1983: Stimulus-dependent blockade of the Na channels of isolated myocardial cells in the rat by the anti-arrhythmia agent N-propyl ajmaline (neogiluritmal) Biulleten' Eksperimental'noi Biologii i Meditsiny 95(4): 55-58
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123
Savina, M.D.; Kudrin, A.N. 1982: Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide Farmakologiia i Toksikologiia 45(2): 63-65
Lishmanov, I.B.; Maslov, L.N.; Krylatov, A.V.; Ugdyzhekova, D.S.; Gilligan, P.; Tam, S.W. 2000: The anti-arrhythmia and pro-arrhythmia properties of sigma-receptor ligands Eksperimental'naia i Klinicheskaia Farmakologiia 63(2): 39-43
Hohnloser, S.H.; Meinertz, T.; Mehender, M.; Geibel, A.; Just, H. 1988: Induction and increase of cardiac arrhythmia by anti-arrhythmia agents Der Internist 29(5): 338-344
Mazur, N.A.; Kurbanov, R.D. 1984: Deterioration in ventricular arrhythmia caused by anti-arrhythmia preparations Terapevticheskii Arkhiv 56(9): 67-70
Bonhorst, D. 1992: Choice of anti-arrhythmia agents: the arrhythmia-patient binomial Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 387-389
Auer, J.; Berent, R.; Eber, B. 2002: Amiodarone in the prevention and treatment of arrhythmia Current Opinion in Investigational Drugs 3(7): 1037-1044
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Trusz-Gluza, M.; Giec, L.; Kośmider, J.; Strzelczyk, B. 1984: Amiodarone in the long-term treatment of arrhythmia Wiadomosci Lekarskie 37(22): 1753-1757